{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:43:15Z","timestamp":1769942595115,"version":"3.49.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fundamental Research Funds for the Central Universities, China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41429-018-0100-9","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T03:36:29Z","timestamp":1537500989000},"page":"978-991","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Potential targets for the development of new antifungal drugs"],"prefix":"10.1038","volume":"71","author":[{"given":"Hao","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-0978","authenticated-orcid":false,"given":"Li","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-8108","authenticated-orcid":false,"given":"Xueshi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,21]]},"reference":[{"key":"100_CR1","doi-asserted-by":"publisher","first-page":"E48","DOI":"10.3390\/microorganisms5030048","volume":"5","author":"M Ikeh","year":"2017","unstructured":"Ikeh M, Ahmed Y, Quinn J. Phosphate acquisition and virulence in human fungal pathogens. Microorganisms. 2017;5:E48 https:\/\/doi.org\/10.3390\/microorganisms5030048 .","journal-title":"Microorganisms"},{"key":"100_CR2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bjid.2016.09.009","volume":"21","author":"JM Gonzalez","year":"2017","unstructured":"Gonzalez JM, Rodriguez CA, Agudelo M, Zuluaga AF, Vesga O. Antifungal pharmacodynamics: Latin America\u2019s perspective. Braz J Infect Dis. 2017;21:79\u201387.","journal-title":"Braz J Infect Dis"},{"key":"100_CR3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41429-017-0009-8","volume":"71","author":"H Su","year":"2018","unstructured":"Su H, et al. Bafilomycin C1 exert antifungal effect through disturbing sterol biosynthesis in Candida albicans. J Antibiot (Tokyo). 2018;71:467\u2013476.","journal-title":"J Antibiot (Tokyo)"},{"key":"100_CR4","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.biopha.2017.11.127","volume":"96","author":"B Sawant","year":"2017","unstructured":"Sawant B, Khan T. Recent advances in delivery of antifungal agents for therapeutic management of candidiasis. Biomed Pharmacother. 2017;96:1478\u20131490.","journal-title":"Biomed Pharmacother"},{"key":"100_CR5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/1040841X.2014.974500","volume":"42","author":"ME Rodrigues","year":"2016","unstructured":"Rodrigues ME, Silva S, Azeredo J, Henriques M. Novel strategies to fight Candida species infection. Crit Rev Microbiol. 2016;42:594\u2013606.","journal-title":"Crit Rev Microbiol"},{"key":"100_CR6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133\u201363.","journal-title":"Clin Microbiol Rev"},{"key":"100_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12906-018-2132-x","volume":"18","author":"GR Rocha","year":"2018","unstructured":"Rocha GR, Florez Salamanca EJ, de Barros AL, Lobo CIV, Klein MI. Effect of tt-farnesol and myricetin on in vitro biofilm formed by Streptococcus mutans and Candida albicans. BMC Complement Altern Med. 2018;18:61 https:\/\/doi.org\/10.1186\/s12906-018-2132-x .","journal-title":"BMC Complement Altern Med"},{"key":"100_CR8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1567-1364.2009.00578.x","volume":"9","author":"D Sanglard","year":"2009","unstructured":"Sanglard D, Coste A, Ferrari S. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res. 2009;9:1029\u201350.","journal-title":"FEMS Yeast Res"},{"key":"100_CR9","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3389\/fmicb.2015.01420","volume":"6","author":"GR Teodoro","year":"2015","unstructured":"Teodoro GR, Ellepola K, Seneviratne CJ, Koga-Ito CY. Potential use of phenolic acids as anti-Candida agents: a review. Front Microbiol. 2015;6:1420 https:\/\/doi.org\/10.3389\/fmicb.2015.01420 .","journal-title":"Front Microbiol"},{"key":"100_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcp.2016.11.019","volume":"133","author":"S Campoy","year":"2017","unstructured":"Campoy S, Adrio JL. Antifungals. Biochem Pharmacol. 2017;133:86\u201396.","journal-title":"Biochem Pharmacol"},{"key":"100_CR11","first-page":"4083","volume":"4","author":"PS Gavarkar","year":"2013","unstructured":"Gavarkar PS, Adnaik RS, Mohite SK. An overview of azole antifungals. Int J Pharm Sci Res. 2013;4:4083\u20139.","journal-title":"Int J Pharm Sci Res"},{"key":"100_CR12","doi-asserted-by":"publisher","first-page":"a019703","DOI":"10.1101\/cshperspect.a019703","volume":"4","author":"T Roemer","year":"2014","unstructured":"Roemer T, Krysan DJ. Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med. 2014;4:a019703 https:\/\/doi.org\/10.1101\/cshperspect.a019703 .","journal-title":"Cold Spring Harb Perspect Med"},{"key":"100_CR13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijantimicag.2017.09.002","volume":"51","author":"NP Wiederhold","year":"2018","unstructured":"Wiederhold NP. The antifungal arsenal: alternative drugs and future targets. Int J Antimicrob Agents. 2018;51:333\u20139.","journal-title":"Int J Antimicrob Agents"},{"key":"100_CR14","unstructured":"Prasad R, Shah AH, Rawal MK. Antifungals: mechanism of action and drug resistance. In: Ramos, J, Sychrov\u00e1, H, Kschischo, M, editors. Yeast membrane transport. Springer: New York, 2016. p. 327\u2013349."},{"key":"100_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/jof2040033","volume":"2","author":"M Poeta Del","year":"2016","unstructured":"Del Poeta M. Special issue: novel antifungal drug discovery. J Fungi (Basel). 2016;2:33 https:\/\/doi.org\/10.3390\/jof2040033 .","journal-title":"J Fungi (Basel)"},{"key":"100_CR16","doi-asserted-by":"publisher","unstructured":"Liu N, Tu J, Dong G, Wang Y, Sheng C. Emerging new targets for the treatment of resistant fungal infections. J. Med. Chem. E-pub ahead of print 16 2018; https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01413) .","DOI":"10.1021\/acs.jmedchem.7b01413)"},{"key":"100_CR17","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1021\/acs.jmedchem.7b00010","volume":"60","author":"AC Flick","year":"2017","unstructured":"Flick AC, et al. Synthetic approaches to the new drugs approved during 2015. J Med Chem. 2017;60:6480\u2013515.","journal-title":"J Med Chem"},{"key":"100_CR18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","volume":"11","author":"FC Odds","year":"2003","unstructured":"Odds FC, Brown AJP, Gow NAR. Antifungal agents: mechanisms of action. Trends Microbiol. 2003;11:272\u20139.","journal-title":"Trends Microbiol"},{"key":"100_CR19","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1016\/j.bmc.2012.04.045","volume":"20","author":"MK Kathiravan","year":"2012","unstructured":"Kathiravan MK, et al. The biology and chemistry of antifungal agents: a review. Bioorg Med Chem. 2012;20:5678\u201398.","journal-title":"Bioorg Med Chem"},{"key":"100_CR20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IDR.S124918","volume":"10","author":"NP Wiederhold","year":"2017","unstructured":"Wiederhold NP. Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist. 2017;10:249\u201359.","journal-title":"Infect Drug Resist"},{"key":"100_CR21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1130-1406(09)70004-X","volume":"26","author":"A Espinel-Ingroff","year":"2009","unstructured":"Espinel-Ingroff A. Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-9). Rev Iberoam Micol. 2009;26:15\u201322.","journal-title":"Rev Iberoam Micol"},{"key":"100_CR22","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1093\/infdis\/jix130","volume":"216","author":"MW McCarthy","year":"2017","unstructured":"McCarthy MW, Kontoyiannis DP, Cornely OA, Perfect JR, Walsh TJ. Novel agents and drug targets to meet the challenges of resistant fungi. J Infect Dis. 2017;216:S474\u2013S483.","journal-title":"J Infect Dis"},{"key":"100_CR23","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1128\/AAC.00349-16","volume":"60","author":"AG Warrilow","year":"2016","unstructured":"Warrilow AG, et al. The investigational drug VT-1129 is a highly potent inhibitor of Cryptococcus species CYP51 but only weakly inhibits the human enzyme. Antimicrob Agents Chemother. 2016;60:4530\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"100_CR24","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1128\/AAC.03707-14","volume":"58","author":"AG Warrilow","year":"2014","unstructured":"Warrilow AG, et al. The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme. Antimicrob Agents Chemother. 2014;58:7121\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"100_CR25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jac\/dkx410","volume":"73","author":"NP Wiederhold","year":"2018","unstructured":"Wiederhold NP, et al. Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus. J Antimicrob Chemother. 2018;73:404\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"100_CR26","doi-asserted-by":"publisher","first-page":"e01541","DOI":"10.1128\/AAC.01541-16","volume":"61","author":"KD James","year":"2017","unstructured":"James KD, Laudeman CP, Malkar NB, Krishnan R, Polowy K. Structure-activity relationships of a series of echinocandins and the discovery of CD101, a highly stable and soluble echinocandin with distinctive pharmacokinetic properties. Antimicrob Agents Chemother. 2017;61:e01541\u201316. https:\/\/doi.org\/10.1128\/AAC.01541-16 .","journal-title":"Antimicrob Agents Chemother"},{"key":"100_CR27","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/cmi.12640","volume":"18","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, et al. CD101: a novel long-acting echinocandin. Cell Microbiol. 2016;18:1308\u201316.","journal-title":"Cell Microbiol"},{"key":"100_CR28","doi-asserted-by":"publisher","first-page":"e02068","DOI":"10.1128\/AAC.02068-16","volume":"61","author":"SA Wring","year":"2017","unstructured":"Wring SA, et al. Preclinical pharmacokinetics and pharmacodynamic target of SCY-078, a first-in-class orally active antifungal glucan synthesis inhibitor, in murine models of disseminated Candidiasis. Antimicrob Agents Chemother. 2017;61:e02068\u201316. https:\/\/doi.org\/10.1128\/AAC.02068-16 .","journal-title":"Antimicrob Agents Chemother"},{"key":"100_CR29","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1073\/pnas.1608304113","volume":"113","author":"JD Oliver","year":"2016","unstructured":"Oliver JD, et al. F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase. Proc Natl Acad Sci USA. 2016;113:12809\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"100_CR30","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/jac\/dkw095","volume":"71","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, et al. T-2307, a novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2. J Antimicrob Chemother. 2016;71:1845\u201355.","journal-title":"J Antimicrob Chemother"},{"key":"100_CR31","unstructured":"Bachhawat AK, Yadav AK. Metabolic pathways as drug targets: targeting the sulphur assimilatory pathways of yeast and fungi for novel drug discovery. In: Ahmad, I., Owais, M., Shahid, M., Aqil, F, editors. Combating fungal infections: problems and remedy. Springer: New York, 2010. p. 327\u2013346."},{"key":"100_CR32","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1099\/00221287-148-8-2617","volume":"148","author":"Z Yang","year":"2002","unstructured":"Yang Z, Pascon RC, Alspaugh A, Cox GM, McCusker JH. Molecular and genetic analysis of the Cryptococcus neoformans MET3 gene and a met3 mutant. Microbiology. 2002;148:2617\u201325.","journal-title":"Microbiology"},{"key":"100_CR33","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1099\/mic.0.27235-0","volume":"150","author":"RC Pascon","year":"2004","unstructured":"Pascon RC, Ganous TM, Kingsbury JM, Cox GM, McCusker JH. Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence. Microbiology. 2004;150:3013\u201323.","journal-title":"Microbiology"},{"key":"100_CR34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.chembiol.2003.09.016","volume":"10","author":"DC Bareich","year":"2003","unstructured":"Bareich DC, Nazi I, Wright GD. Simultaneous in vitro assay of the first four enzymes in the fungal aspartate pathway identifies a new class of aspartate kinase inhibitor. Chem Biol. 2003;10:967\u201373.","journal-title":"Chem Biol"},{"key":"100_CR35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/.61.4.503-532.1997","volume":"61","author":"D Thomas","year":"1997","unstructured":"Thomas D, Surdin-Kerjan Y. Metabolism of sulfur amino acids in Saccharomyces cerevisiae. Microbiol Mol Biol Rev. 1997;61:503\u201332.","journal-title":"Microbiol Mol Biol Rev"},{"key":"100_CR36","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1128\/AAC.01400-06","volume":"51","author":"I Nazi","year":"2007","unstructured":"Nazi I, et al. Role of homoserine transacetylase as a new target for antifungal agents. Antimicrob Agents Chemother. 2007;51:1731\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"100_CR37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ja.2011.37","volume":"64","author":"G Pascale De","year":"2011","unstructured":"De Pascale G, Nazi I, Harrison PH, Wright GD. \u03b2-Lactone natural products and derivatives inactivate homoserine transacetylase, a target for antimicrobial agents. J Antibiot (Tokyo). 2011;64:483\u20137.","journal-title":"J Antibiot (Tokyo)"},{"key":"100_CR38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/yea.3012","volume":"31","author":"EJ Obando Montoya","year":"2014","unstructured":"Obando Montoya EJ, et al. Disrupting the methionine biosynthetic pathway in Candida guilliermondii: characterization of the MET2 gene as counter-selectable marker. Yeast. 2014;31:243\u201351.","journal-title":"Yeast"},{"key":"100_CR39","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00284-017-1276-0","volume":"74","author":"T Linder","year":"2017","unstructured":"Linder T. ATP sulfurylase is essential for the utilization of sulfamate as a sulfur source in the yeast Komagataella pastoris (syn. Pichia pastoris). Curr Microbiol. 2017;74:1021\u20135.","journal-title":"Curr Microbiol"},{"key":"100_CR40","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1091\/mbc.e11-06-0532","volume":"23","author":"E Carrillo","year":"2012","unstructured":"Carrillo E, et al. Characterizing the roles of Met31 and Met32 in coordinating Met4-activated transcription in the absence of Met30. Mol Biol Cell. 2012;23:1928\u201342.","journal-title":"Mol Biol Cell"},{"key":"100_CR41","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/MCB.12.4.1719","volume":"12","author":"D Thomas","year":"1992","unstructured":"Thomas D, Jacquemin I, Surdin-Kerjan Y. MET4, a leucine zipper protein, and centromere-binding factor 1 are both required for transcriptional activation of sulfur metabolism in Saccharomyces cerevisiae. Mol Cell Biol. 1992;12:1719\u201327.","journal-title":"Mol Cell Biol"},{"key":"100_CR42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/AAC.40.1.127","volume":"40","author":"Y Aoki","year":"1996","unstructured":"Aoki Y, et al. Antifungal azoxybacilin exhibits activity by inhibiting gene expression of sulfite reductase. Antimicrob Agents Chemother. 1996;40:127\u201332.","journal-title":"Antimicrob Agents Chemother"},{"key":"100_CR43","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2958.2002.03174.x","volume":"46","author":"GL Wheeler","year":"2002","unstructured":"Wheeler GL, Quinn KA, Perrone G, Dawes IW, Grant CM. Glutathione regulates the expression of gamma-glutamylcysteine synthetase via the Met4 transcription factor. Mol Microbiol. 2002;46:545\u201356.","journal-title":"Mol Microbiol"},{"key":"100_CR44","doi-asserted-by":"publisher","unstructured":"Yurkiv, M et al. Gene of the transcriptional activator MET4 is involved in regulation of glutathione biosynthesis in the methylotrophic yeast Ogataea (Hansenula) polymorpha. FEMS Yeast Res. 18. https:\/\/doi.org\/10.1093\/femsyr\/foy004 (2018).","DOI":"10.1093\/femsyr\/foy004"},{"key":"100_CR45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/lam.12336","volume":"60","author":"NM Tun","year":"2015","unstructured":"Tun NM, et al. Effects of metal ions and hydrogen peroxide on the phenotype of yeasthom6\u0394 mutant. Lett Appl Microbiol. 2015;60:20\u201326.","journal-title":"Lett Appl Microbiol"},{"key":"100_CR46","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/EC.3.5.1287-1296.2004","volume":"3","author":"M Ar\u00e9valo-Rodr\u00edguez","year":"2004","unstructured":"Ar\u00e9valo-Rodr\u00edguez M, Pan X, Boeke JD, Heitman J. FKBP12 controls aspartate pathway flux in Saccharomyces cerevisiae to prevent toxic intermediate accumulation. Eukaryot Cell. 2004;3:1287\u201396.","journal-title":"Eukaryot Cell"},{"key":"100_CR47","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jmii.2016.03.001","volume":"50","author":"PW Tsai","year":"2017","unstructured":"Tsai PW, et al. Candida albicans Hom6 is a homoserine dehydrogenase involved in protein synthesis and cell adhesion. J Microbiol Immunol Infect. 2017;50:863\u201371.","journal-title":"J Microbiol Immunol Infect"},{"key":"100_CR48","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.chembiol.2003.09.015","volume":"10","author":"SL Jacques","year":"2003","unstructured":"Jacques SL, et al. Enzyme-assisted suicide: molecular basis for the antifungal activity of 5-hydroxy-4-oxonorvaline by potent inhibition of homoserine dehydrogenase. Chem Biol. 2003;10:989\u201395.","journal-title":"Chem Biol"},{"key":"100_CR49","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/1097-0061(20000930)16:13<1205::AID-YEA615>3.0.CO;2-C","volume":"16","author":"J Viaene","year":"2000","unstructured":"Viaene J, et al. MET15 as a visual selection marker for Candida albicans. Yeast. 2000;16:1205\u201315.","journal-title":"Yeast"},{"key":"100_CR50","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/EC.00044-10","volume":"9","author":"JM Kingsbury","year":"2010","unstructured":"Kingsbury JM, McCusker JH. Homoserine toxicity in Saccharomyces cerevisiae and Candida albicans homoserine kinase (thr1\u25b3) mutants. Eukaryot Cell. 2010;9:717\u201328.","journal-title":"Eukaryot Cell"},{"key":"100_CR51","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/EC.00045-10","volume":"9","author":"JM Kingsbury","year":"2010","unstructured":"Kingsbury JM, McCusker JH. Fungal homoserine kinase (thr1\u25b3) mutants are attenuated in virulence and die rapidly upon threonine starvation and serum incubation. Eukaryot Cell. 2010;9:729\u201337.","journal-title":"Eukaryot Cell"},{"key":"100_CR52","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1099\/mic.0.2008\/019729-0","volume":"154","author":"JM Kingsbury","year":"2008","unstructured":"Kingsbury JM, McCusker JH. Threonine biosynthetic genes are essential in Cryptococcus neoformans. Microbiology. 2008;154:2767\u201375.","journal-title":"Microbiology"},{"key":"100_CR53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.chembiol.2009.11.017","volume":"17","author":"SA Borisova","year":"2010","unstructured":"Borisova SA, Circello BT, Zhang JK, van der Donk WA, Metcalf WW. Biosynthesis of rhizocticins, antifungal phosphonate oligopeptides produced by Bacillus subtilis ATCC6633. Chem Biol. 2010;17:28\u201337.","journal-title":"Chem Biol"},{"key":"100_CR54","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1016\/j.bmc.2013.06.064","volume":"21","author":"M Gahungu","year":"2013","unstructured":"Gahungu M, et al. Synthesis and biological evaluation of potential threonine synthase inhibitors: Rhizocticin A and Plumbemycin A. Bioorg Med Chem. 2013;21:4958\u201367.","journal-title":"Bioorg Med Chem"},{"key":"100_CR55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12934-015-0240-6","volume":"14","author":"K Ida","year":"2015","unstructured":"Ida K, Ishii J, Matsuda F, Kondo T, Kondo A. Eliminating the isoleucine biosynthetic pathway to reduce competitive carbon outflow during isobutanol production by Saccharomyces cerevisiae. Microb Cell Fact. 2015;14:62 https:\/\/doi.org\/10.1186\/s12934-015-0240-6 .","journal-title":"Microb Cell Fact"},{"key":"100_CR56","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1099\/mic.0.034348-0","volume":"156","author":"JM Kingsbury","year":"2010","unstructured":"Kingsbury JM, McCusker JH. Cytocidal amino acid starvation of Saccharomyces cerevisiae and Candida albicans acetolactate synthase (ilv2\u25b3) mutants is influenced by the carbon source and rapamycin. Microbiology. 2010;156:929\u201339.","journal-title":"Microbiology"},{"key":"100_CR57","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1099\/mic.0.26928-0","volume":"150","author":"JM Kingsbury","year":"2004","unstructured":"Kingsbury JM, Yang Z, Ganous TM, Cox GM, McCusker JH. Cryptococcus neoformans Ilv2p confers resistance to sulfometuron methyl and is required for survival at 37\u2009\u00b0C and in vivo. Microbiology. 2004;150:1547\u201358.","journal-title":"Microbiology"},{"key":"100_CR58","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1128\/EC.5.5.816-824.2006","volume":"5","author":"JM Kingsbury","year":"2006","unstructured":"Kingsbury JM, Goldstein AL, McCusker JH. Role of nitrogen and carbon transport, regulation, and metabolism genes for Saccharomyces cerevisiae survival in vivo. Eukaryot Cell. 2006;5:816\u201324.","journal-title":"Eukaryot Cell"},{"key":"100_CR59","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1128\/AAC.01809-12","volume":"57","author":"DL Richie","year":"2013","unstructured":"Richie DL, et al. Identification and evaluation of novel acetolactate synthase inhibitors as antifungal agents. Antimicrob Agents Chemother. 2013;57:2272\u201380.","journal-title":"Antimicrob Agents Chemother"},{"key":"100_CR60","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.diagmicrobio.2015.03.019","volume":"82","author":"CD Mahl","year":"2015","unstructured":"Mahl CD, et al. Induction of ROS generation by fluconazole in Candida glabrata: activation of antioxidant enzymes and oxidative DNA damage. Diagn Microbiol Infect Dis. 2015;82:203\u20138.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"100_CR61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/B:MYCO.0000038430.20669.80","volume":"158","author":"Y Okamoto","year":"2004","unstructured":"Okamoto Y, Aoki S, Mataga I. Enhancement of amphotericin B activity against Candida albicans by superoxide radical. Mycopathologia. 2004;158:9\u201315.","journal-title":"Mycopathologia"},{"key":"100_CR62","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1021\/pr9005074","volume":"8","author":"Y Xu","year":"2009","unstructured":"Xu Y, et al. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation. J Proteome Res. 2009;8:5296\u2013304.","journal-title":"J Proteome Res"},{"key":"100_CR63","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1128\/AAC.46.10.3113-3117.2002","volume":"46","author":"D Kobayashi","year":"2002","unstructured":"Kobayashi D, et al. Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother. 2002;46:3113\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"100_CR64","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bbagen.2011.02.001","volume":"1810","author":"WQ Chang","year":"2011","unstructured":"Chang WQ, et al. Retigeric acid B exerts antifungal effect through enhanced reactive oxygen species and decreased cAMP. Biochim Biophys Acta. 2011;1810:569\u201376.","journal-title":"Biochim Biophys Acta"},{"key":"100_CR65","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbamem.2017.01.009","volume":"1859","author":"DG Yun","year":"2017","unstructured":"Yun DG, Lee DG. Silymarin exerts antifungal effects via membrane-targeted mode of action by increasing permeability and inducing oxidative stress. Biochim Biophys Acta. 2017;1859:467\u201374.","journal-title":"Biochim Biophys Acta"},{"key":"100_CR66","doi-asserted-by":"publisher","first-page":"E86","DOI":"10.3390\/ph10040086","volume":"10","author":"F Nazzaro","year":"2017","unstructured":"Nazzaro F, Fratianni F, Coppola R. Feo, V. Essential Oils and Antifungal Activity. Pharm (Basel). 2017;10:E86 https:\/\/doi.org\/10.3390\/ph10040086 .","journal-title":"Pharm (Basel)"},{"key":"100_CR67","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1590\/0037-8682-0114-2017","volume":"50","author":"V Saibabu","year":"2017","unstructured":"Saibabu V, Singh S, Ansari MA, Fatima Z, Hameed S. Insights into the intracellular mechanisms of citronellal in Candida albicans: implications for reactive oxygen species-mediated necrosis, mitochondrial dysfunction, and DNA damage. Rev Soc Bras Med Trop. 2017;50:524\u20139.","journal-title":"Rev Soc Bras Med Trop"},{"key":"100_CR68","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1007\/s00253-017-8146-3","volume":"101","author":"H Tian","year":"2017","unstructured":"Tian H, et al. Calcium and oxidative stress mediate perillaldehyde-induced apoptosis in Candida albicans. Appl Microbiol Biotechnol. 2017;101:3335\u201345.","journal-title":"Appl Microbiol Biotechnol"},{"key":"100_CR69","doi-asserted-by":"crossref","first-page":"30895","DOI":"10.1039\/C5RA26092B","volume":"6","author":"Y Ding","year":"2016","unstructured":"Ding Y, et al. HSAF-induced antifungal effects in Candida albicans through ROS-mediated apoptosis. RSC Adv. 2016;6:30895\u2013904.","journal-title":"RSC Adv"},{"key":"100_CR70","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijantimicag.2008.09.014","volume":"33","author":"M An","year":"2009","unstructured":"An M, et al. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. Int J Antimicrob Agents. 2009;33:258\u201363.","journal-title":"Int J Antimicrob Agents"},{"key":"100_CR71","doi-asserted-by":"publisher","first-page":"E30","DOI":"10.1128\/microbiolspec.MB-0008-2014","volume":"3","author":"JE Nett","year":"2015","unstructured":"Nett JE, Andes D. Fungal Biofilms: In vivo models for discovery of anti-biofilm drugs. Microbiol Spectr. 2015;3:E30 https:\/\/doi.org\/10.1128\/microbiolspec.MB-0008-2014 .","journal-title":"Microbiol Spectr"},{"key":"100_CR72","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1567-1364.2010.00664.x","volume":"10","author":"W Shi","year":"2010","unstructured":"Shi W, et al. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents. FEMS Yeast Res. 2010;10:885\u201393.","journal-title":"FEMS Yeast Res"},{"key":"100_CR73","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3389\/fmicb.2016.01925","volume":"7","author":"X Liu","year":"2016","unstructured":"Liu X, et al. Potential antifungal targets against a Candida biofilm based on an enzyme in the arachidonic acid cascade-a review. Front Microbiol. 2016;7:1925 https:\/\/doi.org\/10.3389\/fmicb.2016.01925 .","journal-title":"Front Microbiol"},{"key":"100_CR74","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1099\/jmm.0.46172-0","volume":"54","author":"MA Alem","year":"2005","unstructured":"Alem MA, Douglas LJ. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol. 2005;54:1001\u20135.","journal-title":"J Med Microbiol"},{"key":"100_CR75","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bjid.2013.09.006","volume":"18","author":"NN Mishra","year":"2014","unstructured":"Mishra NN, Ali S, Shukla PK. Arachidonic acid affects biofilm formation and PGE2 level in Candida albicans and non-albicans species in presence of subinhibitory concentration of fluconazole and terbinafine. Braz J Infect Dis. 2014;18:287\u201393.","journal-title":"Braz J Infect Dis"},{"key":"100_CR76","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/1567-1364.12093","volume":"13","author":"R Ells","year":"2013","unstructured":"Ells R, Kemp G, Albertyn J, Kock JL, Pohl CH. Phenothiazine is a potent inhibitor of prostaglandin E2 production by Candida albicans biofilms. FEMS Yeast Res. 2013;13:849\u201355.","journal-title":"FEMS Yeast Res"},{"key":"100_CR77","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12223-016-0483-6","volume":"62","author":"RF Matos de","year":"2017","unstructured":"de Matos RF, et al. Nimesulide inhibits pathogenic fungi: PGE2-dependent mechanisms. Folia Microbiol (Praha). 2017;62:169\u201374.","journal-title":"Folia Microbiol (Praha)"},{"key":"100_CR78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2006.01.016","volume":"119","author":"JY Park","year":"2006","unstructured":"Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol. 2006;119:229\u201340.","journal-title":"Clin Immunol"},{"key":"100_CR79","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1517\/14728220903018932","volume":"13","author":"JP Iyer","year":"2009","unstructured":"Iyer JP, Srivastava PK, Dev R, Dastidar SG, Ray A. Prostaglandin E(2) synthase inhibition as a therapeutic target. Expert Opin Ther Targets. 2009;13:849\u201365.","journal-title":"Expert Opin Ther Targets"},{"key":"100_CR80","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/infdis\/jis594","volume":"206","author":"A Bink","year":"2012","unstructured":"Bink A, et al. The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms. J Infect Dis. 2012;206:1790\u20137.","journal-title":"J Infect Dis"},{"key":"100_CR81","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1590\/S1517-83822014000400031","volume":"45","author":"E Rusu","year":"2015","unstructured":"Rusu E, Radu-Popescu M, Pelinescu D, Vassu T. Treatment with some anti-inflammatory drugs reduces germ tube formation in Candida albicans strains. Braz J Microbiol. 2015;45:1379\u201383.","journal-title":"Braz J Microbiol"},{"key":"100_CR82","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.bmcl.2007.10.033","volume":"17","author":"B C\u00f4t\u00e9","year":"2007","unstructured":"C\u00f4t\u00e9 B, et al. Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors. Bioorg Med Chem Lett. 2007;17:6816\u201320.","journal-title":"Bioorg Med Chem Lett"},{"key":"100_CR83","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/AAC.49.2.584-589.2005","volume":"49","author":"YY Cao","year":"2005","unstructured":"Cao YY, et al. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother. 2005;49:584\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"100_CR84","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijantimicag.2016.01.007","volume":"47","author":"R Kov\u00e1cs","year":"2016","unstructured":"Kov\u00e1cs R, et al. Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosisbiofilms. Int J Antimicrob Agents. 2016;47:304\u201310.","journal-title":"Int J Antimicrob Agents"},{"key":"100_CR85","doi-asserted-by":"crossref","first-page":"294","DOI":"10.15698\/mic2017.09.589","volume":"4","author":"NE Egbe","year":"2017","unstructured":"Egbe NE, Dornelles TO, Paget CM, Castelli LM, Ashe MP. Farnesol inhibits translation to limit growth and filamentation in C. albicans and S. cerevisiae. Microb Cell. 2017;4:294\u2013304.","journal-title":"Microb Cell"},{"key":"100_CR86","first-page":"307","volume":"72","author":"S Di\u017eov\u00e1","year":"2017","unstructured":"Di\u017eov\u00e1 S, Bujd\u00e1kov\u00e1 H. Properties and role of the quorum sensing molecule farnesol in relation to the yeast Candida albicans. Pharmazie. 2017;72:307\u201312.","journal-title":"Pharmazie"},{"key":"100_CR87","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1021\/acs.jnatprod.5b00827","volume":"79","author":"N Ding","year":"2016","unstructured":"Ding N, et al. Bafilomycins and odoriferous sesquiterpenoids from Streptomyces albolongus isolated from Elephas maximus feces. J Nat Prod. 2016;79:799\u2013805.","journal-title":"J Nat Prod"},{"key":"100_CR88","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00294-016-0608-0","volume":"63","author":"A Kr\u00f6ber","year":"2017","unstructured":"Kr\u00f6ber A, et al. The transcriptional regulators SteA and StuA contribute to keratin degradation and sexual reproduction of the dermatophyte Arthroderma benhamiae. Curr Genet. 2017;63:103\u201316.","journal-title":"Curr Genet"},{"key":"100_CR89","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/EC.00208-08","volume":"8","author":"C Zaugg","year":"2009","unstructured":"Zaugg C, et al. Gene expression profiling in the human pathogenic dermatophyte Trichophyton rubrum during growth on proteins. Eukaryot Cell. 2009;8:241\u201350.","journal-title":"Eukaryot Cell"},{"key":"100_CR90","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1099\/mic.0.2006\/003335-0","volume":"153","author":"B L\u00e9chenne","year":"2007","unstructured":"L\u00e9chenne B, et al. Sulphite efflux pumps in Aspergillus fumigatus and dermatophytes. Microbiology. 2007;153:905\u201313.","journal-title":"Microbiology"},{"key":"100_CR91","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1439-0507.2011.02081.x","volume":"55","author":"A Baldo","year":"2012","unstructured":"Baldo A, et al. Mechanisms of skin adherence and invasion by dermatophytes. Mycoses. 2012;55:218\u201323.","journal-title":"Mycoses"},{"key":"100_CR92","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/13693786.2013.794310","volume":"51","author":"A Kasperova","year":"2013","unstructured":"Kasperova A, Kunert J, Raska M. The possible role of dermatophyte cysteine dioxygenase in keratin degradation. Med Mycol. 2013;51:449\u201354.","journal-title":"Med Mycol"},{"key":"100_CR93","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1128\/jb.179.18.5971-5974.1997","volume":"179","author":"D Avram","year":"1997","unstructured":"Avram D, Bakalinsky AT. SSU1 encodes a plasma membrane protein with a central role in a network of proteins conferring sulfite tolerance in Saccharomyces cerevisiae. J Bacteriol. 1997;179:5971\u20134.","journal-title":"J Bacteriol"},{"key":"100_CR94","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1128\/EC.00336-12","volume":"12","author":"F Hennicke","year":"2013","unstructured":"Hennicke F, et al. Factors supporting cysteine tolerance and sulfite production in Candida albicans. Eukaryot Cell. 2013;12:604\u201313.","journal-title":"Eukaryot Cell"},{"key":"100_CR95","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/jid.2013.41","volume":"133","author":"M Grumbt","year":"2013","unstructured":"Grumbt M, et al. Keratin degradation by dermatophytes relies on cysteine dioxygenase and a sulfite efflux pump. J Invest Dermatol. 2013;133:1550\u20135.","journal-title":"J Invest Dermatol"},{"key":"100_CR96","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1074-5521(96)90181-7","volume":"3","author":"RH Lambalot","year":"1996","unstructured":"Lambalot RH, et al. A new enzyme superfamily-the phosphopantetheinyl transferases. Chem Biol. 1996;3:923\u201336.","journal-title":"Chem Biol"},{"key":"100_CR97","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fgb.2010.12.006","volume":"48","author":"G Allen","year":"2011","unstructured":"Allen G, et al. Functional analysis of a mitochondrial phosphopantetheinyl transferase (PPTase) gene pptB in Aspergillus fumigatus. Fungal Genet Biol. 2011;48:456\u201364.","journal-title":"Fungal Genet Biol"},{"key":"100_CR98","doi-asserted-by":"publisher","first-page":"e01504","DOI":"10.1128\/mBio.01504-16","volume":"8","author":"A Johns","year":"2017","unstructured":"Johns A, et al. A nonredundant phosphopantetheinyl transferase, PptA, is a novel antifungal target that directs secondary metabolite, siderophore, and lysine biosynthesis in Aspergillus fumigatus and is critical for pathogenicity. mBio. 2017;8:e01504\u201316. https:\/\/doi.org\/10.1128\/mBio.01504-16 .","journal-title":"mBio"},{"key":"100_CR99","doi-asserted-by":"publisher","first-page":"e0143770","DOI":"10.1371\/journal.pone.0143770","volume":"10","author":"KS Dobb","year":"2015","unstructured":"Dobb KS, et al. Characterisation of the Candida albicans phosphopantetheinyl transferase Ppt2 as a potential antifungal drug target. PLoS One. 2015;10:e0143770 https:\/\/doi.org\/10.1371\/journal.pone.0143770 .","journal-title":"PLoS One"},{"key":"100_CR100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0378-1097(03)00455-5","volume":"224","author":"S Guo","year":"2003","unstructured":"Guo S, Bhattacharjee JK. Molecular characterization of the Candida albicans LYS5 gene and site-directed mutational analysis of the PPTase (Lys5p) domains for lysine biosynthesis. FEMS Microbiol Lett. 2003;224:261\u20137.","journal-title":"FEMS Microbiol Lett"},{"key":"100_CR101","doi-asserted-by":"crossref","first-page":"33142","DOI":"10.1074\/jbc.M305459200","volume":"278","author":"AK Joshi","year":"2003","unstructured":"Joshi AK, Zhang L, Rangan VS, Smith S. Cloning, expression, and characterization of a human 4\u2019-phosphopantetheinyl transferase with broad substrate specificity. J Biol Chem. 2003;278:33142\u20139.","journal-title":"J Biol Chem"},{"key":"100_CR102","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01520-12","volume":"57","author":"N Sun","year":"2013","unstructured":"Sun N, et al. Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants. Antimicrob Agents Chemother. 2013;57:532\u201342.","journal-title":"Antimicrob Agents Chemother"},{"key":"100_CR103","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/EC.05184-11","volume":"10","author":"M Shingu-Vazquez","year":"2011","unstructured":"Shingu-Vazquez M, Traven A. Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy. Eukaryot Cell. 2011;10:1376\u201383.","journal-title":"Eukaryot Cell"},{"key":"100_CR104","doi-asserted-by":"publisher","first-page":"e1005133","DOI":"10.1371\/journal.ppat.1005133","volume":"11","author":"N Grahl","year":"2015","unstructured":"Grahl N, et al. Mitochondrial activity and Cyr1 are key regulators of Ras1 activation of C. albicans virulence pathways. PLoS Pathog. 2015;11:e1005133 https:\/\/doi.org\/10.1371\/journal.ppat.1005133 .","journal-title":"PLoS Pathog"},{"key":"100_CR105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nchembio.2534","volume":"14","author":"CA McLellan","year":"2018","unstructured":"McLellan CA, et al. Inhibiting mitochondrial phosphate transport as an unexploited antifungal strategy. Nat Chem Biol. 2018;14:135\u201341.","journal-title":"Nat Chem Biol"},{"key":"100_CR106","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbrc.2015.06.031","volume":"464","author":"EL Seifert","year":"2015","unstructured":"Seifert EL, Ligeti E, Mayr JA, Sondheimer N, Hajn\u00f3czky G. The mitochondrial phosphate carrier: Role in oxidative metabolism, calcium handling and mitochondrial disease. Biochem. Biophys Res Commun. 2015;464:369\u201375.","journal-title":"Biophys Res Commun"},{"key":"100_CR107","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.abb.2009.12.002","volume":"494","author":"M Guti\u00e9rrez-Aguilar","year":"2010","unstructured":"Guti\u00e9rrez-Aguilar M, P\u00e9rez-Mart\u00ednez X, Ch\u00e1vez E, Uribe-Carvajal S. Saccharomyces cerevisiae, the phosphate carrier is a component of the mitochondrial unselective channel. Arch Biochem Biophys. 2010;494:184\u201391.","journal-title":"Arch Biochem Biophys"},{"key":"100_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15482","volume":"8","author":"F Mietton","year":"2017","unstructured":"Mietton F, et al. Selective BET bromodomain inhibition as an antifungal therapeutic strategy. Nat Commun. 2017;8:15482 https:\/\/doi.org\/10.1038\/ncomms15482 .","journal-title":"Nat Commun"},{"key":"100_CR109","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.phrs.2017.11.015","volume":"129","author":"JM Sahni","year":"2018","unstructured":"Sahni JM, Keri RA. Targeting bromodomain and extraterminal proteins in breast cancer. Pharmacol Res. 2018;129:156\u201376.","journal-title":"Pharmacol Res"},{"key":"100_CR110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12038-016-9600-6","volume":"41","author":"B Padmanabhan","year":"2016","unstructured":"Padmanabhan B, Mathur S, Manjula R, Tripathi S. Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases. J Biosci. 2016;41:295\u2013311.","journal-title":"J Biosci"},{"key":"100_CR111","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drudis.2017.09.011","volume":"23","author":"M Ramadoss","year":"2018","unstructured":"Ramadoss M, Mahadevan V. Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitors. Drug Discov Today. 2018;23:76\u201389.","journal-title":"Drug Discov Today"},{"key":"100_CR112","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2017.02.021","volume":"394","author":"AS Leal","year":"2017","unstructured":"Leal AS, et al. Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer. Cancer Lett. 2017;394:76\u201387.","journal-title":"Cancer Lett"},{"key":"100_CR113","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/138945011501140115112242","volume":"15","author":"H Tripathi","year":"2014","unstructured":"Tripathi H, Luqman S, Meena A, Khan F. Genomic identification of potential targets unique to Candida albicans for the discovery of antifungal agents. Curr Drug Targets. 2014;15:136\u201349.","journal-title":"Curr Drug Targets"},{"key":"100_CR114","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2017.01.003","volume":"133","author":"SB Singh","year":"2017","unstructured":"Singh SB, Young K, Silver LL. What is an \u201cideal\u201d antibiotic? Discovery challenges and path forward. Biochem Pharmacol. 2017;133:63\u201373.","journal-title":"Biochem Pharmacol"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0100-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:31:25Z","timestamp":1684618285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-018-0100-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,21]]},"references-count":114,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["100"],"URL":"https:\/\/doi.org\/10.1038\/s41429-018-0100-9","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,21]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}